The rating affirmation is based on a number of factors, including CHKD’s consistent operating margins, solid liquidity position and dominant market share in the area.
The outlook is stable, reflecting Moody’s expectation that CHKD will keep its strong operating margins on par with recent results.
More articles on healthcare finance:
Hospital to waive ER bill for victims of Oklahoma State University homecoming car crash
For-profit hospital stock report: Week of Nov. 23-27
Turing refuses to lower price for drug with the 5000% price hike
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
